Recently some basic studies have proved that osteocalcin could be an endocrine regulator of glucose metabolism, by enhancing pancreas islets cell proliferation, increasing insulin secretion, and improving insulin resistance (7), which makes osteocalcin possible to perform as a drug for alleviating insulin resistance and metabolic abnormalities if clinical studies come to the same conclusion. The gene discussed is BGLAP; the disease is Insulin resistance.